Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03970616
Title A Study of Tivozanib in Combination With Durvalumab in Subjects With Untreated Advanced Hepatocellular Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AVEO Pharmaceuticals, Inc.
Indications

hepatocellular carcinoma

Therapies

Durvalumab + Tivozanib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.